Hypoglycemia

• Novartis Pharmaceuticals Corporation

  Company1 trialPhase 440 people

• Eli Lilly and Company

  Company1 trialPhase 142 people

• University of Campania Luigi Vanvitelli

  1 trialPhase 4100 people

• Lund University

  1 trialPhase 428 people

• University of Manchester

  1 trialPhase 422 people

• Zealand University Hospital

  1 trialPhase 411 people

• Radboud University Medical Center

  2 trialsPhase 2/325 people

• Albert Einstein College of Medicine

  1 trialPhase 239 people

National Institute of Diabetes and Digestive and Kidney DiseasesUS$664.8k2 grants since 2022

• Examining how the novel S64F MAFA variant produces glucose intolerance or hypoglycemia in a sex-dependent manner

  National Institute of Diabetes and Digestive and Kidney DiseasesVanderbilt University Medical CenterUS$158.4k2022–2027

• A Novel Nitrosylase Prevents Hypoglycemia and Mediates Insulin Resistance

  National Institute of Diabetes and Digestive and Kidney DiseasesCase Western Reserve UniversityUS$506.3k2024–2027